11 Amendments of Philippe JUVIN related to 2011/0401(COD)
Amendment 46 #
Proposal for a regulation
Recital 22
Recital 22
(22) Horizon 2020 should contribute to the attractiveness of the research profession, particularly its industrial and biomedical branches, in the Union. Adequate attention should be paid to the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers, together with other relevant reference frameworks defined in the context of the European Research Area, while respecting their voluntary nature.
Amendment 66 #
Proposal for a regulation
Recital 35
Recital 35
(35) Effective performance management, including evaluation and monitoring, requires development of specific common European performance indicators which can be measured over time; are both realistic and reflect the logic of the intervention; and relevant to the appropriate hierarchy of objectives and activities. Appropriate coordination mechanisms should be put in place between the implementation and monitoring of Horizon 2020, and the monitoring of progress, achievements and functioning of the ERA.
Amendment 227 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 1
Annex I – part III – point 1.1 – paragraph 1
Life long health and wellbeing for all, effective, high-quality and economically sustainable health and care systems, access to health care which is impartial and guaranteed throughout the EU and opportunities for new jobs and growth are the aims of support to research and innovation in response to this challenge and will make a major contribution to Europe 2020.
Amendment 237 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 2
Annex I – part III – point 1.1 – paragraph 2
The cost of Union health and social care systems is rising with care and prevention measures in all ages increasingly expensive, the number of Europeans aged over 65 expected to nearly double from 85 million in 2008 to 151 million by 2060, and those over 80 to rise from 22 to 61 million in the same period. Reducing or containing these costs such that they do not become unsustainable depends in part on ensuring the lifelong health and wellbeing of all and therefore on thereinforcing effective prevention, and awareness- raising of the factors posing a health risk and enabling the treatment and management of disease and disability.
Amendment 245 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 3
Annex I – part III – point 1.1 – paragraph 3
Chronic conditions such as cardiovascular disease (CVD), cancer, diabetes, neurological and mental health disorders, overweight and obesity and various functional limitations are major causes of disability, ill-health, morbidity and premature death, and present considerable social and economic costs.
Amendment 256 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 5
Annex I – part III – point 1.1 – paragraph 5
Amendment 259 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 6
Annex I – part III – point 1.1 – paragraph 6
Meanwhile, drug and vaccine development processes are becoming more expensive and less effective. Persistent health inequalities must be addressed, and access to effective, viable and competent health systems must be ensured for all Europeans.
Amendment 274 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 1
Annex I – part III – point 1.3 – paragraph 1
Effective health promotion, supported by a robust evidence base, and raising awareness of risk factors prevents disease, improves wellbeing and isare cost effective. Health promotion and disease prevention also depend on an understanding of the determinants of health, on European data based on common indicators, on effective preventive tools, such as vaccines, on effective health and disease surveillance and preparedness, and on effective screening programmes.
Amendment 279 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 2
Annex I – part III – point 1.3 – paragraph 2
Successful efforts to prevent, manage, treat and cure disease, disability and reduced functionality are underpinned by the fundamental understanding of their determinants and causes, processes and impacts, as well as factors underlying good health and wellbeing. Effective sharing of data and the linkage of these data with large scale cohort studies, particularly European studies (based, for example, on the Framingham cohort for cardiovascular disease) is also essential, as is the translation of research findings into the clinic, in particular through the conduct of multicentre clinical trials.
Amendment 287 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 3
Annex I – part III – point 1.3 – paragraph 3
An increasing disease and disability burden in the context of an aging population places further demands on health and care sectors. If effective health and care is to be maintained for all ages, efforts are required to improve decision making in prevention and, treatment provision and diagnosis, to identify and support the dissemination of best practice in the health and care sectors, and to support integrated care and the wide uptake of technological, organisational and social innovations empowering in particular older persons as well as disabled persons to remain active and independent. Doing so will contribute to increasing, and lengthening the duration of their physical, social, and mental well-being.
Amendment 290 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 4
Annex I – part III – point 1.3 – paragraph 4
All of these activities shall be undertaken in such a way as to provide support throughout the research and innovation cycle, strengthening the development of new market opportunities and the competitiveness of the European based industries and development of new market opportunitiesupporting SMEs.